These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 37738013)

  • 1. Low-molecular-weight heparin is associated with lower venous thromboembolism events than factor Xa inhibitors in patients with severe blunt trauma: a cohort study from the Trauma Quality Improvement Program.
    Chan SY; Huang JF; Cheng CT; Hsu CP; Liao CH; Fu CY
    Int J Surg; 2024 Jan; 110(1):280-286. PubMed ID: 37738013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative effectiveness of venous thromboembolism prophylaxis options for the patient undergoing total hip and knee replacement: a network meta-analysis.
    Kapoor A; Ellis A; Shaffer N; Gurwitz J; Chandramohan A; Saulino J; Ishak A; Okubanjo T; Michota F; Hylek E; Trikalinos TA
    J Thromb Haemost; 2017 Feb; 15(2):284-294. PubMed ID: 28102615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-molecular-weight heparin versus unfractionated heparin in pediatric traumatic brain injury.
    van Erp IA; Gaitanidis A; El Moheb M; Kaafarani HMA; Saillant N; Duhaime AC; Mendoza AE
    J Neurosurg Pediatr; 2021 Apr; 27(4):469-474. PubMed ID: 33578391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Is monitoring of anti-factor Xa levels required for low molecular weight heparin prophylaxis of venous thromboembolism in critically ill patients?].
    Ding M; Ning Y; Song L; Li P; Xie F; Li S; Wang C
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2024 May; 36(5):461-464. PubMed ID: 38845490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. National Analysis of Outcomes for Adult Trauma Patients With Isolated Severe Blunt Traumatic Brain Injury Following Venous Thromboembolism Prophylaxis.
    Elkbuli A; Watts E; Patel H; Chin B; Wright DD; Inouye M; Nunez D; Rhodes HX
    J Surg Res; 2024 Aug; 300():165-172. PubMed ID: 38815515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Weight-Based Dosing for Low-Molecular-Weight Heparin (Enoxaparin) Administration to Achieve Optimal VTE Prophylaxis in Trauma Patients.
    Thind T; Heye T; Henson C; Reif R; Jensen HK; Kalkwarf KJ; Bhavaraju A; Robertson R; Jenkins A
    Am Surg; 2024 Jun; 90(6):1406-1411. PubMed ID: 38518208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Propensity weighted analysis of chemical venous thromboembolism prophylaxis agents in isolated severe traumatic brain injury: An EAST sponsored multicenter study.
    Ratnasekera AM; Seng SS; Kim D; Ji W; Jacovides CL; Kaufman EJ; Sadek HM; Perea LL; Poloni CM; Shnaydman I; Lee AJ; Sharp V; Miciura A; Trevizo E; Rosenthal MG; Lottenberg L; Zhao W; Keininger A; Hunt M; Cull J; Balentine C; Egodage T; Mohamed AT; Kincaid M; Doris S; Cotterman R; Seegert S; Jacobson LE; Williams J; Moncrief M; Palmer B; Mentzer C; Tackett N; Hranjec T; Dougherty T; Morrissey S; Donatelli-Seyler L; Rushing A; Tatebe LC; Nevill TJ; Aboutanos MB; Hamilton D; Redmond D; Cullinane DC; Falank C; McMellen M; Duran C; Daniels J; Ballow S; Schuster KM; Ferrada P
    Injury; 2024 Sep; 55(9):111523. PubMed ID: 38614835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological interventions for preventing venous thromboembolism in people undergoing bariatric surgery.
    Amaral FC; Baptista-Silva JC; Nakano LC; Flumignan RL
    Cochrane Database Syst Rev; 2022 Nov; 11(11):CD013683. PubMed ID: 36413425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Race does matter: venous thromboembolism in trauma patients with isolated severe pelvic fractures.
    Liasidis P; Benjamin ER; Jakob D; Ding L; Lewis M; Demetriades D
    Eur J Trauma Emerg Surg; 2023 Feb; 49(1):241-251. PubMed ID: 35836009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolonged thromboprophylaxis with low molecular weight heparin for abdominal or pelvic surgery.
    Felder S; Rasmussen MS; King R; Sklow B; Kwaan M; Madoff R; Jensen C
    Cochrane Database Syst Rev; 2019 Mar; 3(3):CD004318. PubMed ID: 30916777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolonged thromboprophylaxis with low molecular weight heparin for abdominal or pelvic surgery.
    Felder S; Rasmussen MS; King R; Sklow B; Kwaan M; Madoff R; Jensen C
    Cochrane Database Syst Rev; 2019 Aug; 8(8):CD004318. PubMed ID: 31449321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factor Xa Inhibitors and Direct Thrombin Inhibitors Versus Low-Molecular-Weight Heparin for Thromboprophylaxis After Total Hip or Total Knee Arthroplasty: A Systematic Review and Meta-Analysis.
    Sun G; Wu J; Wang Q; Liang Q; Jia J; Cheng K; Sun G; Wang Z
    J Arthroplasty; 2019 Apr; 34(4):789-800.e6. PubMed ID: 30685261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aspirin versus low-molecular-weight heparin for thromboprophylaxis after orthopaedic surgery: a systematic review and meta-analysis.
    Wu H; Zhou L; Wang Q; Wang T; Liang S
    Blood Coagul Fibrinolysis; 2024 Jun; 35(4):187-195. PubMed ID: 38652521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unfractionated heparin versus low-molecular-weight heparin for venous thromboembolism prophylaxis in trauma.
    Jacobs BN; Cain-Nielsen AH; Jakubus JL; Mikhail JN; Fath JJ; Regenbogen SE; Hemmila MR
    J Trauma Acute Care Surg; 2017 Jul; 83(1):151-158. PubMed ID: 28426561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determining the impact of culture on venous thromboembolism prevention in trauma patients: A Southwestern Surgical Congress Multicenter trial.
    Regner JL; Shaver CN;
    Am J Surg; 2019 Jun; 217(6):1030-1036. PubMed ID: 30503515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolonged thromboprophylaxis with low molecular weight heparin for abdominal or pelvic surgery.
    Felder S; Rasmussen MS; King R; Sklow B; Kwaan M; Madoff R; Jensen C
    Cochrane Database Syst Rev; 2018 Nov; 11(11):CD004318. PubMed ID: 30481366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct Oral Anticoagulants vs Low-Molecular-Weight Heparin for Thromboprophylaxis in Nonoperative Pelvic Fractures.
    Hamidi M; Zeeshan M; Sakran JV; Kulvatunyou N; O'Keeffe T; Northcutt A; Zakaria ER; Tang A; Joseph B
    J Am Coll Surg; 2019 Jan; 228(1):89-97. PubMed ID: 30359834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuromuscular electrical stimulation for the prevention of venous thromboembolism.
    Hajibandeh S; Hajibandeh S; Antoniou GA; Scurr JR; Torella F
    Cochrane Database Syst Rev; 2017 Nov; 11(11):CD011764. PubMed ID: 29161465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interventions for preventing venous thromboembolism in adults undergoing knee arthroscopy.
    Perrotta C; Chahla J; Badariotti G; Ramos J
    Cochrane Database Syst Rev; 2020 May; 5(5):CD005259. PubMed ID: 32374919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of unfractionated heparin versus low-molecular-weight heparin and fondaparinux for pharmacologic venous thromboembolic prophylaxis in critically ill patients with cancer.
    Van Matre ET; Reynolds PM; MacLaren R; Mueller SW; Wright GC; Moss M; Burnham EL; Ho PM; Vandivier RW; Kiser TH
    J Thromb Haemost; 2018 Dec; 16(12):2492-2500. PubMed ID: 30347498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.